Global Liver Disease Therapeutics Industry to 2026

Dublin, September 28, 2021 (GLOBE NEWSWIRE) – The report “Liver Disease Market Research Report By End User, By Region – Global Forecast to 2026 – Cumulative Impact of COVID-19” has been added to ResearchAndMarkets.com offer. The global liver disease therapeutics market size was estimated at $ 13.37 billion in 2020 …

Read More »

HKEX launches new market access platform for securities trading

“The launch of OCG-C underscores HKEX’s commitment to leveraging the latest technologies to create reliable, resilient and efficient platforms and processes. Hong Kong Exchanges and Clearing Limited (HKEX) launched Orion Central Gateway – Securities Market (OCG-C), offering improved performance and reduced latency, compared to the platform provided by the vendor …

Read More »

ChemoCentryx Announces Japanese Approval of TAVNEOS ™ (Avacopan) for Treatment of Vasculitis Associated with ANCA

Approved for use in Japan in patients with microscopic polyangiitis and granulomatosis with polyangiitis SAN CARLOS, Calif., September 27, 2021 (GLOBE NEWSWIRE) – ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Kissei Pharmaceutical Co., Ltd. has received approval from the Japanese Ministry of Health, Labor, and Welfare (MHLW) to market TAVNEOS …

Read More »